Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

TransMedics (TMDX) EPS (Basic) (2018 - 2025)

Historic EPS (Basic) for TransMedics (TMDX) over the last 8 years, with Q3 2025 value amounting to $0.71.

  • TransMedics' EPS (Basic) rose 44615.38% to $0.71 in Q3 2025 from the same period last year, while for Sep 2025 it was $2.71, marking a year-over-year increase of 17373.74%. This contributed to the annual value of $1.07 for FY2024, which is 23896.1% up from last year.
  • According to the latest figures from Q3 2025, TransMedics' EPS (Basic) is $0.71, which was up 44615.38% from $1.03 recorded in Q2 2025.
  • Over the past 5 years, TransMedics' EPS (Basic) peaked at $1.03 during Q2 2025, and registered a low of -$0.78 during Q3 2023.
  • In the last 5 years, TransMedics' EPS (Basic) had a median value of -$0.08 in 2023 and averaged -$0.0.
  • As far as peak fluctuations go, TransMedics' EPS (Basic) plummeted by 21200.0% in 2023, and later soared by 133333.33% in 2024.
  • Over the past 5 years, TransMedics' EPS (Basic) (Quarter) stood at -$0.46 in 2021, then soared by 56.52% to -$0.2 in 2022, then skyrocketed by 160.0% to $0.12 in 2023, then skyrocketed by 75.0% to $0.21 in 2024, then soared by 238.1% to $0.71 in 2025.
  • Its last three reported values are $0.71 in Q3 2025, $1.03 for Q2 2025, and $0.76 during Q1 2025.